Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Even though type 2 diabetes mellitus (T2DM) represents a worldwide chronic health issue
that affects about 462 million people, specific underlying determinants of insulin resistance …

Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285
million people with diabetes mellitus worldwide, approximately one third have signs of DR …

With increasing global prevalence of diabetes, diabetic retinopathy (DR) is set to be the
principle cause of vision impairment in many countries. DR affects a third of people with …

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and
one of the major causes of blindness worldwide. The pathogenesis of DR has been …

Introduction: Diabetes mellitus is a systemic disease with complications that include sight-
threatening diabetic retinopathy. It is essential to understand the risk factors of diabetic …

Purpose To determine the prevalence and risk factors for diabetic retinopathy (DR) and sight-
threatening diabetic retinopathy (STDR) in a multi-hospital-based DR screening programme …

There is growing evidence that chronic inflammation plays a role in both the development
and progression of diabetic retinopathy. There is also evidence that molecules produced as …

The aim of the present study was to investigate the correlation of neutrophil to lymphocyte
ratio (NLR), mean platelet volume (MPV), and platelet distribution width (PDW) with diabetic …

Introduction: Diabetic retinopathy (DR) is the most common complication and cause of visual
impairment in diabetes patients. The pathogenesis is not fully understood, but several …